Accuracy of Self-Monitoring of Blood Glucose: Impact on Diabetes Management Decisions During Pregnancy

Abstract

PURPOSE

This study tested the hypothesis that the accuracy of self-monitoring of blood glucose (SMBG) values of patients with diabetes during pregnancy deviates substantially from reference values.

METHODS

The patients' glucose values were measured on 6 different SMBG meters; reference values were from the HemoCue B Glucose Analyzer. Over a 5-year period, 1973 comparisons between SMBG values and reference values were recorded during clinic visits and used for this study. Data were analyzed for percent of values that varied more than ±10.5% and ±15.5% from the reference value. Out-of-range data at each variance level were analyzed to determine the impact on medical management if decisions were based solely on SMBG values.

RESULTS

One third of SMBG readings deviated significantly, which could adversely affect treatment for half of these patients if diabetes management was based on SMBG values. At the 10.5% deviation level, 34% of SMBG meter readings were out of range; 54% of these would have implied erroneous treatment. At the 15.5% deviation level, 18% were out of range; 63% of these would have implied erroneous management.

CONCLUSIONS

The accuracy of home meters should be verified at regular intervals, and SMBG values should not be the sole criterion for diabetes management during pregnancy.

Get full access to this article

View all access options for this article.

References

1. American Diabetes Association . Consensus statement: is quality control in SMBG adequate? Clinical practice recommendations. Diabetes Care. 1990;13(suppl 1):43-43.

2. American Diabetes Association . Consensus statement: what is the current technology? Clinical practice recommendations. Diabetes Care. 1996; 19(suppl 1):S64-S64.

3. Pohl SL , Gonder-Frederick L , Cox DJ , Evans WS . Self-measurement of blood glucose concentration: clinical significance of patient-generated measurements. Diabetes Care. 1985;8:617-618.

4. Clarke WL , Cox D , Gonder-Frederick LA , Carter W , Pohl SL . Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care. 2000;23:136-136.

5. Havlin CE , Parvin CA , Cryer PE . The accuracy of blood glucose monitoring devices. Clin Diabetes. 1991;Nov/Dec: 92-93.

6. Carr SR , Slocum J , Tefft L , Haydon B , Carpenter M. Precision of office-based blood glucose meters in screening for gestational diabetes. Am J Obstet Gynecol. 1995;0ct: 1267-1272.

7. Brunner GA , Ellmerer M , Sendlhofer G , et al. Validation of home blood glucose meters with respect to clinical and analytical approaches. Diabetes Care. 1998;21:585-590.

8. Poirier JY , LePrieur N , Campion L , Guilhem I , Allannic H , Maugendre D. Clinical and statistical evaluation of self-monitoring blood glucose meters. Diabetes Care. 1998;21: 1919-1924.

9. Wiener K.

Whole blood glucose: what are we actually measuring?

Ann Clin Biochem. 1995;32:1-8.

10.

10. Geeting DG , Suther CA , Sylbert P. Determination of glucose in serum and whole blood: statistical relationships between values obtained by different methods. Clin Chem. 1972;18:976-979.

11.

11. US Department of Health and Human Services . Clinical Laboratory Improvement Amendments (CLIA) regional letter. Washington, DC: US Department of Health and Human Services; July 14, 1998. Letter 98-06.

12.

12. FDA 510(K) Federal Register 25112 (1995).

13.

13. Voss EM , Cembrowski GS . Analytical performance of the HemoCue B Glucose Analyzer using whole blood samples. Arch Pathol Lab Med. 1993; 117:711-713.

14.

14. Jacobs, Ellis . Core Analyte Number PTS 94-1 (PTS-75). Check Sample. 1994;10:1-9.

15.

15. Teng RY , Punla O , Koos BJ . Predictive value of HemoCue capillary whole blood glucose measurements in pregnancy. Soc Gynecol Invest. 1995:618-620.

16.

16. Weiss PAM , Kainer F , Haeusler MCH , Pürstner P , Urasch R. A rapid test for diabetes screening during pregnancy [in German]. Geburtsh u Frauenheilk. 1994;54:697-701.

17.

17. Carr DB , Gabbe S. Gestational diabetes: detection, management, and implications. Clin Diabetes. 1998;16:4-11.

18.

18. Scheffler RM , Feuchtbaum LB , Phibbs CS . Prevention: the cost-effectiveness of the California Diabetes and Pregnancy Program. Am J Public Health. 1992;82:168-175.

19.

19. Bergenstal R , Pearson J , Cembrowski GS , Bina D , Davidson J , List S. Identifying variables associated with inaccurate self-monitoring of blood glucose: proposed guidelines to improve accuracy. Diabetes Educ. 2000; 26:981-989.